Sentence examples for laboratories in developing countries from inspiring English sources

The development of new genomic technologies may enable laboratories in developing countries to "leapfrog" and avoid the development of costly laboratory systems similar to those that are being implemented in Organization for Economic Co-operation and Development countries, where separate specialist testing capacities exist for each of the many microbiological families.

With the signing of the Stockholm convention on POPs and the development of global monitoring programs, there is an increased need for laboratories in developing countries to determine PCBs and OCPs.

The approach is inexpensive and easy to use and could potentially be used in a 'pen-side' setting 'in the field' or by smaller less well-equipped laboratories in developing countries.

Unique challenges pertaining to chemical safety exist for chemical laboratories in developing countries, not least of which are financial constraints that often leave safety concerns as the last priority.

Secondly, we point out that some mouse models of tuberculosis in laboratories in developing countries, where exposure to environmental mycobacteria is large, mimic neglected aspects of human disease more closely than do low-dose infections in hyper-susceptible immunologically naïve mice in the USA or Europe.

Recycling and re-use of laboratory materials, adaptation of equipment, and substitution of reagents are ever-present features in laboratories in developing countries.

Determination of MIC may not be practicable in routine laboratory practice, particularly outside of a reference laboratory in developing countries.

Another method for detecting HCV RNA is reverse transcript polymerase chain reaction (RT-PCR), which is not feasible due to its high cost; it is not used routinely in the diagnostic laboratories, especially in developing countries [9], [10].

However, because of the slow growth and the particular requirements of H. pylori culture, this approach is not reliable for use in most routine clinical laboratories, principally in developing countries.

However, because of the slow growth and the particular requirements of H.pylori culture, this approach is not reliable for use in most routine clinical laboratories, principally in developing countries.

Rather than shipping all samples to laboratories in developed countries solely for HSV-2 screening, use of Kalon by on-site operators in field laboratories is a more feasible and cost-effective alternative.